Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Human Genomics|January 10, 2026
Epimutation analysis reveals involvement of SLIT2/ROBO signaling pathway in painful diabetic neuropathyKatarzyna Malgorzata Kwiatkowska, Paolo Garagnani, Francesca Ferraresi, et al.Neurobiology of Disease|April 8, 2026
Longitudinal and combined assessment of 24(S)-hydroxycholesterol and Neurofilament light chain in the early stages of Huntington's diseaseLidia Sarro, Marta Valenza, Alessia Mongelli, et al.Plos One|April 7, 2022
Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort studyWen-Yi Yang, Benedetta Izzi, Adam P Bress, et al.Journal of Hypertension|September 9, 2016
Xanthine oxidase gene variants and their association with blood pressure and incident hypertension: a population studyLieke E J M Scheepers, Fang-Fei Wei, Katarzyna Stolarz-Skrzypek, et al.International Journal of Cancer|July 21, 2025
The anti-aging Klotho protects glioblastoma macrophages from radiotherapy-induced inflammation and predicts immunotherapy responseAndrea Galluzzo, Martina Maffezzini, Maria Luisa Fumagalli, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish populationFang-Fei Wei, Lutgarde Thijs, Zhen-Yu Zhang, et al.International Journal of Molecular Sciences|July 9, 2022
Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic NeuropathyMilena Ślęczkowska, Rowida Almomani, Margherita Marchi, et al.Hypertension (Dallas, Tex. : 1979)|November 26, 2014
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish populationYan-Ping Liu, Yu-Mei Gu, Lutgarde Thijs, et al.Journal of the American Heart Association|January 28, 2015
Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugsTimo P Hiltunen, Kati M Donner, Antti-Pekka Sarin, et al.BMC Medical Genetics|April 29, 2017
PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish populationWen-Yi Yang, Thibault Petit, Nicholas Cauwenberghs, et al.Pageof 10